The Defense Logistics Agency Troop Support has a requirement for the supply of Antidote Treatment Nerve Agent Auto-Injector (ATNAA), NSN 6505-01-362-7427.
The ATNAA provides Atropine Injection and Pralidoxime Chloride Injection in separate chambers as sterile, pyrogen-free solutions for intramuscular injection.
The proposed contract will be a firm-fixed price requirements contract. All responsible sources may submit a proposal and shall be considered by the Agency. The successful contractor shall have FDA approval to sell ATNAA before award of the contract.
Solicitation SPE2DP-18-R-0112 is expected to be issued on or around September 2018. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at and FedBizOps.
Interested parties should contact Danielle Delaney (215-737-2998) for any questions/comments.